AMRX
Price
$8.54
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
10 days until earnings call
ORGO
Price
$2.95
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
14 days until earnings call
Ad is loading...

AMRX vs ORGO

Header iconAMRX vs ORGO Comparison
Open Charts AMRX vs ORGOBanner chart's image
Amneal Pharmaceuticals
Price$8.54
Change-$0.00 (-0.00%)
Volume$743.48K
CapitalizationN/A
Organogenesis Holdings
Price$2.95
Change-$0.00 (-0.00%)
Volume$905.15K
CapitalizationN/A
View a ticker or compare two or three
AMRX vs ORGO Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMRX vs. ORGO commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Buy and ORGO is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AMRX: $8.54 vs. ORGO: $2.95)
Brand notoriety: AMRX and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 58% vs. ORGO: 211%
Market capitalization -- AMRX: $1.87B vs. ORGO: $374.78M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 3 bearish.
  • ORGO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMRX and ORGO are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +0.83% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -5.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

AMRX is expected to report earnings on Feb 27, 2025.

ORGO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than ORGO($375M). AMRX has higher P/E ratio than ORGO: AMRX (90.00) vs ORGO (70.25). AMRX YTD gains are higher at: 40.692 vs. ORGO (-27.873). AMRX has higher annual earnings (EBITDA): 400M vs. ORGO (36M). ORGO has more cash in the bank: 104M vs. AMRX (91.5M). ORGO has less debt than AMRX: ORGO (119M) vs AMRX (2.75B). AMRX has higher revenues than ORGO: AMRX (2.39B) vs ORGO (433M).
AMRXORGOAMRX / ORGO
Capitalization1.87B375M499%
EBITDA400M36M1,111%
Gain YTD40.692-27.873-146%
P/E Ratio90.0070.25128%
Revenue2.39B433M553%
Total Cash91.5M104M88%
Total Debt2.75B119M2,312%
FUNDAMENTALS RATINGS
AMRX vs ORGO: Fundamental Ratings
AMRX
ORGO
OUTLOOK RATING
1..100
1485
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
37100
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
3852
P/E GROWTH RATING
1..100
4116
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (78) in the Financial Conglomerates industry is in the same range as AMRX (95) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORGO (100) in the Financial Conglomerates industry. This means that AMRX’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (92) in the Financial Conglomerates industry is in the same range as AMRX (98) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as ORGO (52) in the Financial Conglomerates industry. This means that AMRX’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (16) in the Financial Conglomerates industry is in the same range as AMRX (41) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXORGO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with ORGO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+1.67%
ORGO - AMRX
41%
Loosely correlated
+5.36%
TLRY - AMRX
38%
Loosely correlated
+2.37%
CRON - AMRX
36%
Loosely correlated
+0.68%
VTRS - AMRX
35%
Loosely correlated
+2.80%
EBS - AMRX
31%
Poorly correlated
+8.29%
More